According to Ye dong’s findings, MT treatment inhibits SIRT1 exerting antitumor activity in human osteosarcoma cells, and the results suggested that MT is an inhibitor targeting SIRT1 signaling [64]. The gene discussed is SIRT1; the disease is osteosarcoma.